Envista Holdings (NVST): are the analysts right?

Envista Holdings · Health Care · ref. ETF XLV · 52 calls · price $26.82
What the company does: Envista Holdings conçoit, fabrique et vend des produits dentaires aux États-Unis et à l'international.
📈 1-year price
$27.13+34.6% over range
Jul 8, 25low $18.89 · high $30.26Jul 7, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Hold
36% recommend buying · 11 analysts

🎯 Analyst price target on NVST

High target · 1 analyst$33+23.0%
Median target · 11 analysts$29+8.1%
Low target · 1 analyst$21-21.7%
Current price$26.82

🗳️ The analyst consensus

Analyst breakdown · 11 (6 months)
Strong Buy0%
Buy36%
Hold64%
Sell0%
Strong Sell0%

✅ Historical analyst reliability on NVST

📊 What $1,000 invested in Envista Holdings would be worth

In short — $1,000 invested in Envista Holdings 10 years ago would be worth $916 today, i.e. -1%/yr on average. Best year: 2021 (+34%), worst: 2023 (-29%). Price performance, excluding dividends.

If I'd invested $1,000 in Envista Holdings

InvestmentWorth todayGain
1 years ago$1,385+38%
3 years ago$783-22%
5 years ago$781-22%
since inception (2019)$916-8%

Return by year (Envista Holdings)

YearReturn$1,000 invested at year start
2026 (YTD)+21%$1,215 (+21%)
2025+14%$1,385 (+38%)
2024-21%$1,095 (+10%)
2023-29%$783 (-22%)
2022-25%$585 (-42%)
2021+34%$781 (-22%)
2020+11%$865 (-14%)
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.

🔎 Detailed analyses

👥 Analysts & forecasts📊 Returns & performance
📈 Fundamentals, technical momentum and live news will show here on the final site (loaded live from the same origin as the API).

📋 All analyst calls on NVST

Barclays
Jun 11, 26
▲ Overweight · 🎯$32
Price at call : $24.6 — upside +30%
Today : $26.82 — upside +19%
🎯 on NVST : no call matured yet · 📊 on Health : 47.8% · +1.6% (186 calls)
in progress (365j)
matures : Jun 11, 27
JP Morgan
May 7, 26
■ Neutral neutral · not a buy · 🎯$29
Price at call : $24.24 — gap to target +20%
Today : $26.82 — gap to target +8%
🎯 on NVST : no call matured yet · 📊 on Health : 48.4% · +4.8% (126 calls)
in progress (365j)
matures : May 7, 27
▲ Outperform · 🎯$33
Price at call : $24.24 — upside +36%
Today : $26.82 — upside +23%
🎯 on NVST : 100% (1 call matured) · 📊 on Health : 35.3% · -9.2% (34 calls)
in progress (365j)
matures : May 7, 27
Baird
May 7, 26
▲ Outperform · 🎯$31
Price at call : $24.29 — upside +28%
Today : $26.82 — upside +16%
🎯 on NVST : 100% (1 call matured) · 📊 on Health : 48.6% · +2.9% (70 calls)
in progress (365j)
matures : May 7, 27
■ Equal-Weight neutral · not a buy · 🎯$21
Price at call : $26.8 — gap to target -22%
Today : $26.82 — gap to target -22%
🎯 on NVST : no call matured yet · 📊 on Health : 33.3% · -9.0% (159 calls)
in progress (365j)
matures : Apr 24, 27
Citigroup
Apr 15, 26
■ Neutral neutral · not a buy · 🎯$29
Price at call : $26.94 — gap to target +8%
Today : $26.82 — gap to target +8%
🎯 on NVST : no call matured yet · 📊 on Health : 56.8% · +16.5% (118 calls)
in progress (365j)
matures : Apr 15, 27
▲ Outperform · 🎯$30
Price at call : $26.67 — upside +12%
Today : $26.82 — upside +12%
🎯 on NVST : 100% (1 call matured) · 📊 on Health : 35.3% · -9.2% (34 calls)
in progress (365j)
matures : Apr 8, 27
Barclays
Feb 11, 26
▲ Overweight · 🎯$34
Price at call : $30.26 — upside +12%
Today : $26.82 — upside +27%
🎯 on NVST : no call matured yet · 📊 on Health : 47.8% · +1.6% (186 calls)
in progress (365j)
matures : Feb 11, 27
Mizuho
Feb 10, 26
■ Neutral neutral · not a buy · 🎯$27
Price at call : $30.17 — gap to target -11%
Today : $26.82 — gap to target +1%
🎯 on NVST : 100% (1 call matured) · 📊 on Health : 58.2% · +13.7% (55 calls)
in progress (365j)
matures : Feb 10, 27
JP Morgan
Feb 6, 26
■ Neutral neutral · not a buy · 🎯$26
Price at call : $29.36 — gap to target -11%
Today : $26.82 — gap to target -3%
🎯 on NVST : no call matured yet · 📊 on Health : 48.4% · +4.8% (126 calls)
in progress (365j)
matures : Feb 6, 27
Stifel
Feb 6, 26
▲ Buy · 🎯$31
Price at call : $29.36 — upside +6%
Today : $26.82 — upside +16%
🎯 on NVST : 100% (1 call matured) · 📊 on Health : 47.2% · +12.4% (89 calls)
in progress (365j)
matures : Feb 6, 27
Wells Fargo
Feb 6, 26
■ Equal-Weight neutral · not a buy · 🎯$26
Price at call : $29.36 — gap to target -11%
Today : $26.82 — gap to target -3%
🎯 on NVST : no call matured yet · 📊 on Health : 46% · +2.8% (126 calls)
in progress (365j)
matures : Feb 6, 27
■ Neutral neutral · not a buy · 🎯$25
Price at call : $29.36 — gap to target -15%
Today : $26.82 — gap to target -7%
🎯 on NVST : no call matured yet · 📊 on Health : 41.4% · +4.5% (116 calls)
in progress (365j)
matures : Feb 6, 27
Stifel
Feb 4, 26
▲ Buy · 🎯$27
Price at call : $23.66 — upside +14%
Today : $26.82 — upside +1%
🎯 on NVST : 100% (1 call matured) · 📊 on Health : 47.2% · +12.4% (89 calls)
in progress (365j)
matures : Feb 4, 27
UBS
Feb 3, 26
■ Neutral neutral · not a buy · 🎯$25
Price at call : $22.91 — gap to target +9%
Today : $26.82 — gap to target -7%
🎯 on NVST : no call matured yet · 📊 on Health : 47.1% · +16.6% (102 calls)
in progress (365j)
matures : Feb 3, 27
Piper Sandler
Jan 30, 26
■ Neutral neutral · not a buy · 🎯$21
Price at call : $23.26 — gap to target -10%
Today : $26.82 — gap to target -22%
🎯 on NVST : no call matured yet · 📊 on Health : 41.4% · +4.5% (116 calls)
in progress (365j)
matures : Jan 30, 27
Mizuho
Jan 20, 26
■ Neutral neutral · not a buy · 🎯$24
Price at call : $24.34 — gap to target -1%
Today : $26.82 — gap to target -11%
🎯 on NVST : 100% (1 call matured) · 📊 on Health : 58.2% · +13.7% (55 calls)
in progress (365j)
matures : Jan 20, 27
JP Morgan
Dec 16, 25
■ Neutral neutral · not a buy · 🎯$22
Price at call : $21.85 — gap to target +1%
Today : $26.82 — gap to target -18%
🎯 on NVST : no call matured yet · 📊 on Health : 48.4% · +4.8% (126 calls)
in progress (365j)
matures : Dec 16, 26
Barclays
Dec 9, 25
▲ Overweight · 🎯$24
Price at call : $22.1 — upside +9%
Today : $26.82 — upside -11%
🎯 on NVST : no call matured yet · 📊 on Health : 47.8% · +1.6% (186 calls)
in progress (365j)
matures : Dec 9, 26
Mizuho
Aug 1, 25
▼ Underperform · 🎯$18
Price at call : $20.48 — upside -12%
Today : $26.82 — upside -33%
🎯 on NVST : 100% (1 call matured) · 📊 on Health : 58.2% · +13.7% (55 calls)
in progress (365j)
matures : Aug 1, 26
Stifel
Aug 1, 25
▲ Buy · 🎯$25
Price at call : $20.48 — upside +22%
Today : $26.82 — upside -7%
🎯 on NVST : 100% (1 call matured) · 📊 on Health : 47.2% · +12.4% (89 calls)
in progress (365j)
matures : Aug 1, 26
■ Equal-Weight neutral · not a buy · 🎯$17
Price at call : $20.48 — gap to target -17%
Today : $26.82 — gap to target -37%
🎯 on NVST : no call matured yet · 📊 on Health : 33.3% · -9.0% (159 calls)
in progress (365j)
matures : Aug 1, 26
Wells Fargo
Aug 1, 25
■ Equal-Weight neutral · not a buy · 🎯$19
Price at call : $20.48 — gap to target -7%
Today : $26.82 — gap to target -29%
🎯 on NVST : no call matured yet · 📊 on Health : 46% · +2.8% (126 calls)
in progress (365j)
matures : Aug 1, 26
■ Neutral neutral · not a buy · 🎯$19
Price at call : $20.83 — gap to target -9%
Today : $26.82 — gap to target -29%
🎯 on NVST : no call matured yet · 📊 on Health : 41.4% · +4.5% (116 calls)
in progress (365j)
matures : Aug 1, 26
UBS
Jul 29, 25
■ Neutral neutral · not a buy · 🎯$22
Price at call : $19.96 — gap to target +10%
Today : $26.82 — gap to target -18%
🎯 on NVST : no call matured yet · 📊 on Health : 47.1% · +16.6% (102 calls)
in progress (365j)
matures : Jul 29, 26
▲ Outperform · 🎯$23
Price at call : $20.38 — upside +13%
Today : $26.82 — upside -14%
🎯 on NVST : 100% (1 call matured) · 📊 on Health : 35.3% · -9.2% (34 calls)
in progress (365j)
matures : Jul 9, 26
Baird
May 27, 25
▲ Outperform · 🎯$23
Price at call : $18.53 — upside +24%
Today : $26.82 — upside -14%
Expected +24% · Actual +28% · Reason (≥ +15%) : ✓ Yes
🎯 on NVST : 100% (1 call matured) · 📊 on Health : 48.6% · +2.9% (70 calls)
+27.7%
stock +28% · XLV +15%
UBS
May 5, 25
■ Neutral neutral · not a buy · 🎯$18
Price at call : $16.39 — gap to target +10%
Today : $26.82 — gap to target -33%
🎯 on NVST : no call matured yet · 📊 on Health : 47.1% · +16.6% (102 calls)
in progress (365j)
matures : May 5, 26
Baird
May 2, 25
■ Neutral neutral · not a buy · 🎯$21
Price at call : $16.99 — gap to target +24%
Today : $26.82 — gap to target -22%
🎯 on NVST : 100% (1 call matured) · 📊 on Health : 48.6% · +2.9% (70 calls)
in progress (365j)
matures : May 2, 26
Piper Sandler
Apr 30, 25
■ Neutral neutral · not a buy · 🎯$17
Price at call : $16.34 — gap to target +4%
Today : $26.82 — gap to target -37%
🎯 on NVST : no call matured yet · 📊 on Health : 41.4% · +4.5% (116 calls)
in progress (365j)
matures : Apr 30, 26
▲ Buy · 🎯$23
Price at call : $16.08 — upside +43%
Today : $26.82 — upside -14%
Expected +43% · Actual +61% · Reason (≥ +15%) : ✓ Yes
🎯 on NVST : 100% (1 call matured) · 📊 on Health : 61.4% · +19.8% (83 calls)
+61.3%
stock +61% · XLV +4%
UBS
Mar 10, 25
■ Neutral neutral · not a buy · 🎯$21
Price at call : $17.13 — gap to target +23%
Today : $26.82 — gap to target -22%
🎯 on NVST : no call matured yet · 📊 on Health : 47.1% · +16.6% (102 calls)
in progress (365j)
matures : Mar 10, 26
JP Morgan
Mar 6, 25
■ Neutral neutral · not a buy · 🎯$19
Price at call : $18.43 — gap to target +3%
Today : $26.82 — gap to target -29%
🎯 on NVST : no call matured yet · 📊 on Health : 48.4% · +4.8% (126 calls)
in progress (365j)
matures : Mar 6, 26
■ Equal-Weight neutral · not a buy · 🎯$19
Price at call : $17.83 — gap to target +7%
Today : $26.82 — gap to target -29%
🎯 on NVST : no call matured yet · 📊 on Health : 33.3% · -9.0% (159 calls)
in progress (365j)
matures : Mar 6, 26
Needham
Mar 6, 25
■ Hold neutral · not a buy
🎯 on NVST : no call matured yet · 📊 on Health : 45.5% · +1.8% (134 calls)
in progress (365j)
matures : Mar 6, 26
Needham
Feb 25, 25
■ Hold neutral · not a buy
🎯 on NVST : no call matured yet · 📊 on Health : 45.5% · +1.8% (134 calls)
in progress (365j)
matures : Feb 25, 26
Wells Fargo
Feb 6, 25
■ Equal-Weight neutral · not a buy · 🎯$21
Price at call : $21.25 — gap to target -1%
Today : $26.82 — gap to target -22%
🎯 on NVST : no call matured yet · 📊 on Health : 46% · +2.8% (126 calls)
in progress (365j)
matures : Feb 6, 26
Baird
Feb 6, 25
■ Neutral neutral · not a buy · 🎯$23
Price at call : $21.79 — gap to target +6%
Today : $26.82 — gap to target -14%
🎯 on NVST : 100% (1 call matured) · 📊 on Health : 48.6% · +2.9% (70 calls)
in progress (365j)
matures : Feb 6, 26
■ Equal-Weight neutral · not a buy · 🎯$20
Price at call : $21.79 — gap to target -8%
Today : $26.82 — gap to target -25%
🎯 on NVST : no call matured yet · 📊 on Health : 33.3% · -9.0% (159 calls)
in progress (365j)
matures : Feb 6, 26
Needham
Feb 6, 25
■ Hold neutral · not a buy
🎯 on NVST : no call matured yet · 📊 on Health : 45.5% · +1.8% (134 calls)
in progress (365j)
matures : Feb 6, 26
■ Neutral neutral · not a buy · 🎯$18
Price at call : $20.13 — gap to target -11%
Today : $26.82 — gap to target -33%
🎯 on NVST : no call matured yet · 📊 on Health : 41.4% · +4.5% (116 calls)
in progress (365j)
matures : Feb 3, 26
Jefferies
Jan 23, 25
■ Hold neutral · not a buy · 🎯$22
Price at call : $21.45 — gap to target +3%
Today : $26.82 — gap to target -18%
🎯 on NVST : no call matured yet · 📊 on Health : 48% · +9.7% (98 calls)
in progress (365j)
matures : Jan 23, 26
Mizuho
Dec 4, 24
▼ Underperform · 🎯$20
Price at call : $20.57 — upside -3%
Today : $26.82 — upside -25%
Expected -3% · Actual -2% · Reason (≤ −15%) : ✗ No
🎯 on NVST : 100% (1 call matured) · 📊 on Health : 58.2% · +13.7% (55 calls)
+2.1%
stock -2% · XLV +5%
Piper Sandler
Oct 31, 24
■ Neutral neutral · not a buy · 🎯$17
Price at call : $20.94 — gap to target -19%
Today : $26.82 — gap to target -37%
🎯 on NVST : no call matured yet · 📊 on Health : 41.4% · +4.5% (116 calls)
in progress (365j)
matures : Oct 31, 25
Needham
Oct 31, 24
■ Hold neutral · not a buy
🎯 on NVST : no call matured yet · 📊 on Health : 45.5% · +1.8% (134 calls)
in progress (365j)
matures : Oct 31, 25
Baird
Oct 31, 24
■ Neutral neutral · not a buy · 🎯$22
Price at call : $20.97 — gap to target +5%
Today : $26.82 — gap to target -18%
🎯 on NVST : 100% (1 call matured) · 📊 on Health : 48.6% · +2.9% (70 calls)
in progress (365j)
matures : Oct 31, 25
■ Market Perform neutral · not a buy · 🎯$23
Price at call : $20.97 — gap to target +10%
Today : $26.82 — gap to target -14%
🎯 on NVST : 100% (1 call matured) · 📊 on Health : 44.4% · -4.7% (9 calls)
in progress (365j)
matures : Oct 31, 25
Stifel
Oct 23, 24
▲ Buy · 🎯$21
Price at call : $19.02 — upside +10%
Today : $26.82 — upside -22%
Expected +10% · Actual +7% · Reason (≥ +15%) : ✗ No
🎯 on NVST : 100% (1 call matured) · 📊 on Health : 47.2% · +12.4% (89 calls)
+7.0%
stock +7% · XLV -2%
Wells Fargo
Oct 8, 24
■ Equal-Weight neutral · not a buy · 🎯$20
Price at call : $18.2 — gap to target +10%
Today : $26.82 — gap to target -25%
🎯 on NVST : no call matured yet · 📊 on Health : 46% · +2.8% (126 calls)
in progress (365j)
matures : Oct 8, 25
▲ Outperform · 🎯$23
Price at call : $18.84 — upside +22%
Today : $26.82 — upside -14%
Expected +22% · Actual +9% · Reason (≥ +15%) : ✗ No
🎯 on NVST : 100% (1 call matured) · 📊 on Health : 35.3% · -9.2% (34 calls)
+9.1%
stock +9% · XLV -11%
▼ Underperform · 🎯$19
Price at call : $21.92 — upside -13%
Today : $26.82 — upside -29%
Expected -13% · Actual -6% · Reason (≤ −15%) : ✗ No
🎯 on NVST : 100% (1 call matured) · 📊 on Health : 44.4% · -4.7% (9 calls)
+5.8%
stock -6% · XLV +1%
■ Market Perform neutral · not a buy
🎯 on NVST : no call matured yet · 📊 on Health : 47.4% · +30.6% (19 calls)
in progress (365j)
matures : Feb 7, 25
JPI AI Analyst AI assistant · JPI Invest
Answers based on the tool’s data · not financial advice · full version (free)